1. Home
  2. EXPO vs ZLAB Comparison

EXPO vs ZLAB Comparison

Compare EXPO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

N/A

Current Price

$88.48

Market Cap

3.1B

ML Signal

N/A

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$22.02

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EXPO
ZLAB
Founded
1967
2013
Country
United States
China
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
EXPO
ZLAB
Price
$88.48
$22.02
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
★ $90.67
$34.21
AVG Volume (30 Days)
382.2K
★ 1.1M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 1.39%
N/A
EPS Growth
N/A
★ 38.46
EPS
★ 1.83
N/A
Revenue
★ $582,014,000.00
$460,156,000.00
Revenue This Year
$14.34
N/A
Revenue Next Year
$8.95
$22.47
P/E Ratio
$48.51
★ N/A
Revenue Growth
4.21
★ 15.33
52 Week Low
$51.91
$15.96
52 Week High
$90.51
$29.02

Technical Indicators

Market Signals
Indicator
EXPO
ZLAB
Relative Strength Index (RSI) 73.22 40.01
Support Level $64.40 $21.71
Resistance Level $90.51 $26.64
Average True Range (ATR) 2.56 1.34
MACD -0.03 -0.21
Stochastic Oscillator 81.08 7.53

Price Performance

Historical Comparison
EXPO
ZLAB

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: